Orlistat

CAS 96829-58-2 7 current records 2 historicalSmall Molecule

Who holds supplier records for Orlistat? 7 organisations hold a current record for Orlistat: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3) and Taiwan (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Orlistat: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/orlistat

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Orlistat. Country is the organisation's recorded country, not necessarily the manufacturing site.

India3Taiwan1Country not recorded for 3
  • ARGUS PHARMACEUTICALS LTD
    Active DMF 26455 · latest filing Sept 2012
  • Biocon Limited
    Active DMF 26101, 38096 · latest filing Apr 2023
    India
  • CHONGQING ZEIN PHARMACEUTICAL CO LTD
    Active DMF 24885 · latest filing Apr 2011
  • Divis Laboratories
    Active DMF 35884 · latest filing Apr 2021
    India Company GMP cert on record
  • Formosa Laboratories, Inc.
    Active DMF 23978 · latest filing Jul 2010
    Taiwan Company GMP cert on record
  • Shandong New Time Pharmaceutical Co Ltd
    Active DMF 29914 · latest filing Oct 2015
    Company GMP cert on record
  • Sun Pharmaceutical Industries Limited
    Active DMF 32338, 22357 · latest filing Jan 2018
    India Company GMP cert on record
Need Orlistat sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Orlistat are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Overview

Orlistat is a drug designed to treat obesity by inhibiting the absorption of dietary fats. It works by blocking the enzyme lipase, which is necessary for the digestion of fats.

Chemical identity

IUPAC name
[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
Canonical SMILES
CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
InChIKey
AHLBNYSZXLDEJQ-FWEHEUNISA-N
Synonyms
Xenical API, orlistat, Tetrahydrolipstatin, Xenical, Orlipastat, Alli, (-)-Tetrahydrolipstatin, THLP, tetrahydrolipastatin, Ro 18-0647/002, orlistatum, Ro-18-0647/002

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Intestinal Lipase Inhibitor
Mechanism of action
Lipase Inhibitors

Therapeutic areas

Obesity

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Orlistat?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Orlistat: ARGUS PHARMACEUTICALS LTD, Biocon Limited (India), CHONGQING ZEIN PHARMACEUTICAL CO LTD, Divis Laboratories (India), Formosa Laboratories, Inc. (Taiwan), Shandong New Time Pharmaceutical Co Ltd and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Orlistat Drug Master Files are active?

ARGUS PHARMACEUTICALS LTD (DMF 26455), Biocon Limited (DMF 26101, 38096), CHONGQING ZEIN PHARMACEUTICAL CO LTD (DMF 24885), Divis Laboratories (DMF 35884), Formosa Laboratories, Inc. (DMF 23978), Shandong New Time Pharmaceutical Co Ltd (DMF 29914) and Sun Pharmaceutical Industries Limited (DMF 32338, 22357). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Orlistat records mean?

2 organisations have only inactive Type II DMFs for Orlistat. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Orlistat supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Orlistat?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.